Article
TYK2 in Cancer Metastases: Genomic and Proteomic Discovery
19 Aug 2021
Abstract excerpt
Advances in genomic analysis and proteomic tools have rapidly expanded identification of biomarkers and molecular targets important to cancer development and metastasis. On an individual basis, personalized medicine approaches allow better characterization of tumors and patient prognosis, leading to more targeted treatments by detection of specific gene mutations, overexpression, or activity. Genomic and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
